diabetes

Novo Lures Sanofi Pitchman as Diabetes Battle Heats Up
Bloomberg
Wed, 03/27/13 - 10:26 am
Sanofi
Novo Nordisk
diabetes
Is Merck's Type 2 Diabetes Blockbuster in Trouble?
Motley Fool
Wed, 03/27/13 - 09:54 am
Merck
Januvia
diabetes
Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Motley Fool
Tue, 03/26/13 - 09:20 am
diabetes
FDA
Eli Lilly
Boehringer Ingelheim
empagliflozin
2 Can't-Miss FDA Rulings Next Week
Motley Fool
Sun, 03/24/13 - 12:27 pm
JNJ
Invokana
type 2 diabetes
diabetes
pulmonary arterial hypertension
Treprostinil
Johnson & Johnson Invokana PDUFA Preview
Motley Fool
Thu, 03/21/13 - 10:52 am
Invokana
diabetes
canagliflozin
Novo Nordisk’s Oral Insulin Successfully Completes Early Study
Bloomberg
Wed, 03/20/13 - 11:54 am
insulin
Novo Nordisk
diabetes
Merrion
Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta® (linagliptin) tablets in patients with type 2 diabetes and albuminuria
Yahoo
Tue, 03/19/13 - 10:43 am
Eli Lilly
Boehringer Ingelheim
Tradjenta
diabetes
albuminuria
Novo Nordisk Says Trial Shows Victoza Helps Patients Lose Weight
Bloomberg
Mon, 03/18/13 - 11:22 am
Novo Nordisk
Victoza
obesity
diabetes
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thu, 03/14/13 - 11:15 am
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
J&J Seeks EU Nod for Combo Drug
Yahoo/Zacks
Tue, 03/12/13 - 11:24 am
Europe
JNJ
diabetes
canagliflozin
metformin
Gilead drug reduces chest pain episodes in diabetics -study
Reuters
Mon, 03/11/13 - 11:06 am
diabetes
Gilead
angina
Ranexa
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Seeking Alpha
Sat, 03/9/13 - 12:29 pm
type 2 diabetes
JNJ
diabetes
canagliflozin
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Forbes
Fri, 03/8/13 - 11:03 am
JNJ
diabetes
canagliflozin
Takeda Put Actos Sales Ahead of User Safety, Witness Says
Bloomberg
Wed, 03/6/13 - 09:59 am
Takeda
Actos
diabetes
type 2 diabetes
How Serious Is This News for Diabetes Drugmakers?
Motley Fool
Sat, 03/2/13 - 04:00 pm
pancreatitis
diabetes
type 2 diabetes
Merck
AstraZeneca
Bristol-Myers Squibb
Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk
Bloomberg
Tue, 02/26/13 - 10:04 am
Merck
diabetes
Bristol-Myers Squibb
pancreatitis
Januvia
Byetta
Glaxo Sued By Maryland AG Over Avandia Risks
Pharmalot
Fri, 02/22/13 - 10:43 am
GSK
Avandia
diabetes
Maryland
U.S. rejection of Novo drug seen temporary but costly
Yahoo/Reuters
Thu, 02/21/13 - 12:03 pm
Novo Nordisk
Tresiba
diabetes
Takeda Faces First Trial Over Actos Diabetes Drug in L.A.
Bloomberg
Tue, 02/19/13 - 10:11 am
Takeda
Actos
diabetes

Pages